Literature DB >> 3668531

2-Pyrrolidinone in human cerebrospinal fluid: a major constituent of total gamma-aminobutyric acid.

K D Haegele1, J J Schwartz, J Schoun, A H Schmitt, P J Schechter.   

Abstract

2-Pyrrolidinone, the lactam of gamma-aminobutyric acid (GABA), is identified as the major constituent of total GABA in human CSF. Structural elucidation was done by mass spectrometry. In lumbar CSF of four patients, 2-pyrrolidinone represented about 54% of GABA found after acid hydrolysis, thus accounting for essentially all of the hitherto unknown GABA fraction in CSF.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3668531     DOI: 10.1111/j.1471-4159.1987.tb01006.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

Review 1.  Clinical relevance of measuring GABA concentrations in cerebrospinal fluid.

Authors:  P J Schechter; A Sjoerdsma
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

Review 2.  Review: Normal and abnormal central nervous system GABA metabolism in childhood.

Authors:  J Jaeken; P Casaer; K D Haegele; P J Schechter
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Free-GABA levels in the cerebrospinal fluid of patients suffering from several neurological diseases Its potential use for the diagnosis of diseases which course with inflammation and tissular necrosis.

Authors:  A T Zepeda; F J Ortiz Nesme; J Méndez-Franco; E Otero-Siliceo; M Pérez de la Mora
Journal:  Amino Acids       Date:  1995-09       Impact factor: 3.520

Review 4.  Clinical pharmacology of vigabatrin.

Authors:  P J Schechter
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

5.  Interpretable machine learning-derived nomogram model for early detection of diabetic retinopathy in type 2 diabetes mellitus: a widely targeted metabolomics study.

Authors:  Jushuang Li; Chengnan Guo; Tao Wang; Yixi Xu; Fang Peng; Shuzhen Zhao; Huihui Li; Dongzhen Jin; Zhezheng Xia; Mingzhu Che; Jingjing Zuo; Chao Zheng; Honglin Hu; Guangyun Mao
Journal:  Nutr Diabetes       Date:  2022-08-05       Impact factor: 4.725

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.